|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.08 USD | +5.88% |
|
+3.85% | -66.67% |
| May. 21 | Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 22 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
On November 6, 2018, the Board of Directors of ContraVir Pharmaceuticals, Inc. removed acting from Dr. Robert Foster's title as Chief Executive Officer and appointed Dr. Foster as a director of the company.
| 1st Jan change | Capi. | |
|---|---|---|
| -66.67% | 5.91M | |
| +20.17% | 126B | |
| +24.67% | 118B | |
| +23.67% | 27.87B | |
| -17.74% | 20.95B | |
| -15.75% | 16.92B | |
| -15.21% | 16.18B | |
| +11.91% | 14.84B | |
| -47.10% | 14.79B | |
| +54.50% | 14.08B |
HEPION PHARMACEUTICALS, INC. 
